Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015, Article ID 735868, 5 pages
http://dx.doi.org/10.1155/2015/735868
Case Report

Primary Hyperparathyroidism and Hyperthyroidism in a Patient with Myotonic Dystrophy: A Case Report and Review of the Literature

Department of Endocrinology and Internal Medicine, Tahar Sfar University Hospital of Mahdia, Hiboun District, 5100 Mahdia, Tunisia

Received 11 April 2015; Accepted 19 May 2015

Academic Editor: Wayne V. Moore

Copyright © 2015 Yosra Cherif et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Ørngreen, P. Arlien-Søborg, M. Duno, J. M. Hertz, and J. Vissing, “Endocrine function in 97 patients with myotonic dystrophy type 1,” Journal of Neurology, vol. 259, no. 5, pp. 912–920, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Molina, J. I. Lara, P. Riobo et al., “Primary hyperthyroidism and associated hyperparathyroidism in a patient with myotonic dystrophy: steinert with hyperthyroidism and hyperparathyroidism,” The American Journal of the Medical Sciences, vol. 311, no. 6, pp. 296–298, 1996. View at Google Scholar
  3. N. L. Rosenberg, J. H. Diliberti, A. M. Andrews, and N. R. Buist, “Myotonic dystrophy and hyperparathyroidism: association with neurofibromatosis and multiple endocrine adenomatosis type 2A,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 51, no. 12, pp. 1578–1580, 1988. View at Google Scholar
  4. K. S. Steinbeck and J. N. Carter, “Thyroid abnormalities in patients with myotonic dystrophy,” Clinical Endocrinology, vol. 17, no. 5, pp. 449–456, 1982. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Fukazawa, T. Sakurada, K. Yoshida et al., “Thyroid function in patients with myotonic dystrophy,” Clinical Endocrinology, vol. 32, no. 4, pp. 485–490, 1990. View at Google Scholar
  6. G. Bonanni, S. Pennazzato, C. Santarossa et al., “Myotonic dystrophy: lack of correlation between CTG expansion and thyroid and carbohydrate status,” Basic and Applied Myology, vol. 7, no. 5, pp. 345–349, 1997. View at Google Scholar
  7. F. I. Lee and D. T. D. Hughes, “Systemic effects in dystrophia myotonica,” Brain, vol. 87, no. 3, pp. 521–536, 1964. View at Publisher · View at Google Scholar · View at Scopus
  8. A. H. Zargar, M. H. Bhat, M. A. Ganie et al., “Polyglandular endocrinopathy in myotonic dystrophy: letter to editor,” Neurology India, vol. 50, no. 1, pp. 105–106, 2002. View at Google Scholar · View at Scopus
  9. D. M. Peterson, J. V. Bounds Jr., and W. E. Karnes, “Clinical observations on thyrotoxicosis coexisting with myotonic dystrophy,” Mayo Clinic Proceedings, vol. 51, no. 3, pp. 176–179, 1976. View at Google Scholar
  10. T. Okuno, K. Mori, K. Furomi, T. Takeoka, and K. Kondo, “Myotonic dystrophy and hyperthyroidism,” Neurology, vol. 31, no. 1, pp. 91–93, 1981. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Pagliara, E. Spagnuolo, L. Ambrosone, A. Barbato, P. Tesauro, and M. Rambaldi, “Hyperthyroidism and Addison's disease in a patient with myotonic dystrophy,” Archives of Internal Medicine, vol. 145, no. 5, pp. 919–920, 1985. View at Google Scholar
  12. C. Daumerie, N. Lannoy, J.-P. Squifflet, G. Verellen, and C. Verellen-Dumoulin, “High CTG repeat number in nodular thyroid tissue from a myotonic dystrophy patient,” Journal of Medical Genetics, vol. 31, no. 11, pp. 891–892, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. J. B. Stanbury, R. R. Goldsmith, and M. Gillis, “Myotonic dystrophy associated with thyroid disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 14, no. 11, pp. 1437–1443, 1954. View at Publisher · View at Google Scholar
  14. W. D. Drucker, L. P. Rowland, K. Sterling, and N. P. Christy, “On the function of the endocrine glands in myotonic muscular dystrophy,” The American Journal of Medicine, vol. 31, pp. 941–950, 1961. View at Google Scholar
  15. W. J. Kuhl, I. S. Halper, and R. M. Dowben, “Thyroxine and triiodothyronine turnover studies in dystrophia myotonica,” Journal of Clinical Endocrinology and Metabolism, vol. 21, pp. 1592–1595, 1961. View at Google Scholar
  16. J. Brumlik and R. J. Maier, “Myxedema and myotonic dystrophy,” Archives of Internal Medicine, vol. 129, no. 1, pp. 120–122, 1972. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Sagel, L. A. Distiller, J. E. Morley, and H. Isaacs, “Letter: normal thyrotropin-releasing hormone response in myotonia dystrophica,” Archives of Neurology, vol. 33, no. 7, p. 520, 1976. View at Publisher · View at Google Scholar
  18. P. Lecomte, F. Lamisse, J. H. Soutoul, and J. J. Morel, “Endocrine aspects of Steinert's disease,” Semaine des Hopitaux, vol. 53, no. 4, pp. 227–233, 1977. View at Google Scholar · View at Scopus
  19. O. A. Henriksen, J. A. Sundsfjord, and R. Nyberg Hansen, “Evaluation of the endocrine functions in dystrophia myotonica,” Acta Neurologica Scandinavica, vol. 58, no. 3, pp. 178–189, 1978. View at Google Scholar · View at Scopus
  20. G. Tredici and A. Coletti, “Dystrophia myotonica and hypothyroidism,” Journal of Neurology, vol. 218, no. 3, pp. 215–218, 1978. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Okuno, K. Mori, T. Aizawa, T. Takeoka, and K. Furumi, “A case of myotonic dystrophy associated with hyperthyroidism (author's transl),” Nihon Naika Gakkai Zasshi, vol. 68, no. 1, pp. 74–80, 1979. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Rioperez, J. M. Botella, A. Palacio, I. Abaitua, J. L. Trueba, and J. R. Ricoy-Campo, “Myotonic dystrophy associated with thyroid disease,” Journal of the Neurological Sciences, vol. 43, no. 3, pp. 357–366, 1979. View at Publisher · View at Google Scholar · View at Scopus
  23. I. A. Borda, J. R. Morales, V. G. Camargo, C. F. Miranda, and A. P. Pérez-Medel, “Hyperthyroidism and Steinert's disease. Presentation of a new case and review of the literature,” Revista Clinica Espanola, vol. 164, no. 5, pp. 343–345, 1982. View at Google Scholar · View at Scopus
  24. Y. Konagaya, H. Honda, M. Konagaya, S. Yanagimoto, T. Sakakibara, and T. Takayanagi, “Myotonic dystrophy associated with hyperthyroidism,” Nihon Naika Gakkai Zasshi, vol. 72, no. 10, pp. 1391–1397, 1983. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Pizzi, S. Fusi, G. Forti, and G. Marconi, “Study of endocrine function in myotonic dystrophy,” The Italian Journal of Neurological Sciences, vol. 6, no. 4, pp. 457–467, 1985. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Takase, N. Okita, H. Sakuma et al., “Endocrinological abnormalities in myotonic dystrophy: consecutive studies of eight tolerance tests in 26 patients,” Tohoku Journal of Experimental Medicine, vol. 153, no. 4, pp. 355–374, 1987. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Passeri, E. Bugiardini, V. A. Sansone et al., “Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies,” Journal of the Neurological Sciences, vol. 331, no. 1-2, pp. 132–135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Harada, T. Matsumoto, K. Ikeda, S. Fukumoto, Y. Ihara, and E. Ogata, “Association of primary hyperparathyroidism with myotonic dystrophy in two patients,” Archives of Internal Medicine, vol. 147, 777, no. 4, p. 778, 1987. View at Google Scholar
  29. M. Kinoshita, T. Komori, T. Ohtake, R. Takahashi, R. Nagasawa, and K. Hirose, “Abnormal calcium metabolism in myotonic dystrophy as shown by the Ellsworth-Howard test and its relation to CTG triplet repeat length,” Journal of Neurology, vol. 244, no. 10, pp. 613–622, 1997. View at Publisher · View at Google Scholar
  30. E. Garcia Delgado and J. Ruiz Galiana, “Association of primary hyperparathyroidism with myotonic dystrophy in two patients,” Archives of Internal Medicine, vol. 148, no. 1, pp. 237–241, 1988. View at Publisher · View at Google Scholar · View at Scopus
  31. P. G. Middleton, S. Posen, and G. Shannon, “Hyperparathyroidism in a patient with myotonic dystrophy,” Journal of the Royal Society of Medicine, vol. 82, no. 4, article 227, 1989. View at Google Scholar · View at Scopus
  32. A. Downie and E. M. Jepson, “Hyperparathyroidism in a patient with myotonic dystrophy,” Journal of the Royal Society of Medicine, vol. 83, no. 1, p. 58, 1990. View at Google Scholar · View at Scopus
  33. E. Bell, A. R. Lorimer, and J. Hinnie, “Association between myotonic dystrophy and primary hyperparathyroidism,” Journal of International Medical Research, vol. 22, no. 5, pp. 296–298, 1994. View at Google Scholar · View at Scopus
  34. A. W. Kung, “Neuromuscular complications of thyrotoxicosis,” Clinical Endocrinology, vol. 67, no. 5, pp. 645–650, 2007. View at Google Scholar
  35. F. Hanisch, T. Kraya, M. Kornhuber, and S. Zierz, “Diagnostic impact of myotonic discharges in myofibrillar myopathies,” Muscle & Nerve, vol. 47, no. 6, pp. 845–848, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. D. F. de Almeida, T. V. Lissa, and A. C. Melo Jr., “Myotonic potentials in statin-induced rhabdomyolysis,” Arquivos de Neuro-Psiquiatria, vol. 66, no. 4, pp. 891–893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Kinoshita, R. Takahashi, T. Hasegawa et al., “(CTG)n expansions in various tissues from a myotonic dystrophy patient,” Muscle and Nerve, vol. 19, no. 2, pp. 240–242, 1996. View at Google Scholar · View at Scopus